Cargando…
The DELIVER Trial: the Beginning of the End of Ejection Fraction Tyranny
It has been reported at the 2022 European Society of Cardiology Congress that the DELIVER trial has met its primary outcome – a relative reduction of 18% in a composite of worsening heart failure (HF) or cardiovascular death. These results, added to evidence from previously reported pivotal trials w...
Autor principal: | Bayes-Genis, Antoni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Radcliffe Cardiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947924/ https://www.ncbi.nlm.nih.gov/pubmed/36845219 http://dx.doi.org/10.15420/ecr.2022.44 |
Ejemplares similares
-
SECURE, ADVOR and REVIVED: Clinical Trials Presented at ESC 2022
por: Mendieta, Guiomar
Publicado: (2022) -
Highlights of Acute Coronary Syndromes
por: Recio-Mayoral, Alejandro
Publicado: (2022) -
Comment on the ESC Guidelines 2022 for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
por: Cuervo, David Calvo
Publicado: (2023) -
ESC Congress 2022 Imaging Highlights
por: Puntmann, Valentina O, et al.
Publicado: (2023) -
New Trial Evidence on Heart Failure: Highlights from the European Society of Cardiology Congress 2021
por: Ferrannini, Giulia, et al.
Publicado: (2022)